• 1
    Hennenberg M, Trebicka J, Sauerbruch T, Heller J. Mechanisms of extrahepatic vasodilation in portal hypertension. Gut 2008; 57: 130014.
  • 2
    Steib A, Freys G, Gohard R, et al. Tissue oxygenation during liver transplantation. Critical Care Medicine 1992; 20: 97783.
  • 3
    Moller S, Bendtsen F, Henriksen JH. Effect of volume expansion on systemic hemodynamics and central and arterial blood volume in cirrhosis. Gastroenterology 1995; 109: 191725.
  • 4
    Skagen CL, Said A. Vasoconstrictor use in liver transplantation: is there evidence for rational use? Minerva Gastroenterologica e Dietollogica 2010; 56: 27996.
  • 5
    Wagener G, Gubitosa G, Renz J, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transplantation 2008; 14: 166470.
  • 6
    Lebrec D. Pharmacological treatment of portal hypertension: present and future. Journal of Hepatology 1998; 28: 896907.
  • 7
    Huang YT, Lin HC, Chang YY, Yang YY, Lee SD, Hong CY. Hemodynamic effects of synephrine treatment in portal hypertensive rats. Japanese Journal of Pharmacology 2001; 85: 1838.
  • 8
    Mastai R, Bosch J, Navasa M, et al. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis. Journal of Hepatology 1987; 4: 719.
  • 9
    Salooja N, Perry DJ. Thrombelastography. Blood Coagulation and Fibrinolysis 2001; 12: 32737.
  • 10
    Groenland TH, Porte RJ. Antifibrinolytics in liver transplantation. International Anesthesiology Clinics 2006; 44: 8397.
  • 11
    Mehrabi A, Golling M, Kashfi A, et al. Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transplantation 2005; 11: 17487.
  • 12
    Aggarwal S, Kang Y, Freeman JA, Fortunato FL, Pinsky MR. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. Transplantation Proceedings 1987; 19: 545.
  • 13
    Zhang LP, Li M, Yang L. Effects of different vasopressors on hemodynamics in patients undergoing orthotopic liver transplantation. Chinese Medical Journal 2005; 118: 19528.
  • 14
    Massicotte L, Perrault M-A, Denault AY, et al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation 2010; 89: 9207.
  • 15
    MacGilchrist AJ, Sumner D, Reid JL. Impaired pressor reactivity in cirrhosis: evidence for a peripheral vascular defect. Hepatology 1991; 13: 68994.
  • 16
    Vaughan RB, Angus JA, Angus PW. Vasoconstrictor responses are normal but prostanoid-mediated vasodilatation is enhanced in human cirrhotic mesenteric arteries. Journal of Gastroenterology and Hepatology 2005; 20: 115864.
  • 17
    Salcedo A, Garijo J, Monge L, et al. Adrenergic response of splanchnic arteries from cirrhotic patients: role of nitric oxide, prostanoids, and reactive oxygen species. Experimental Biolology and Medicine 2007; 232: 13607.
  • 18
    Morelli A, Lange M, Ertmer C, et al. Short-term effects of phenylephrine on systemic and regional hemodynamics in patients with septic shock: a crossover pilot study. Shock 2008; 29: 44651.
  • 19
    Garutti MartinezI, Olmedilla L, Perez-Pena JM, et al. Response to clamping of the inferior vena cava as a factor for predicting postreperfusion syndrome during liver transplantation. Anesthesia and Analgesia 1997; 84: 2549.
  • 20
    Morelli A, Ertmer C, Rehberg S, et al. Phenylephrine versus norepinephrine for initial hemodynamic support of patients with septic shock: a randomized, controlled trial. Critical Care 2008; 12: R143-R.
  • 21
    Cacciarelli TV, Keeffe EB, Moore DH, et al. Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. Archives of Surgery 1999; 134: 259.
  • 22
    de BoerMT, Christensen MC, Asmussen M, et al. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesthesia and Analgesia 2008; 106: 3244.
  • 23
    Ramos E, Dalmau A, Sabate A, et al. Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them. Liver Transplantation 2003; 9: 13207.
  • 24
    Steib A, Freys G, Lehmann C, Meyer C, Mahoudeau G. Intraoperative blood losses and transfusion requirements during adult liver transplantation remain difficult to predict. Canadian Journal of Anesthesia 2001; 48: 10759.
  • 25
    Shangraw RE, Winter R, Hromco J, Robinson ST, Gallaher EJ. Amelioration of lactic acidosis with dichloroacetate during liver transplantation in humans. Anesthesiology 1994; 81: 112738.
  • 26
    Spiess BD, Tuman KJ, McCarthy RJ, et al. Oxygen consumption and mixed venous oxygen saturation monitoring during orthotopic liver transplantation. Journal of Clinical Monitoring 1992; 8: 711.
  • 27
    Leary TS, Klinck JR, Hayman G, et al. Measurement of liver tissue oxygenation after orthotopic liver transplantation using a multiparameter sensor. A pilot study. Anaesthesia 2002; 57: 122833.
  • 28
    Yang W, Hafaz T, Thompson CS, et al. Direct measurement of hepatic tissue hypoxia by using a novel tcpO2/pCO2 monitoring system in comparison with near-infrared spectroscopy. Liver Intenational 2003; 23: 16370.
  • 29
    Ryu HG, Jung CW, Lee CS, Lee J. Nafamostat mesilate attenuates Postreperfusion Syndrome during liver transplantation. American Journal of Transplantation 2011; 11: 97783.